These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
45. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma. Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468 [TBL] [Abstract][Full Text] [Related]
46. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI. Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962 [TBL] [Abstract][Full Text] [Related]
47. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339 [TBL] [Abstract][Full Text] [Related]
48. [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging]. Plathow C; Walz M; Lichy MP; Aschoff P; Pfannenberg C; Bock H; Eschmann SM; Claussen CD; Schlemmer HP Radiologe; 2008 Apr; 48(4):384-96. PubMed ID: 17891370 [TBL] [Abstract][Full Text] [Related]
49. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
50. Whole-body Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514 [TBL] [Abstract][Full Text] [Related]
51. FDG PET and PET/CT. Krause BJ; Schwarzenböck S; Souvatzoglou M Recent Results Cancer Res; 2013; 187():351-69. PubMed ID: 23179888 [TBL] [Abstract][Full Text] [Related]
52. Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors. Carlbom L; Caballero-Corbalán J; Granberg D; Sörensen J; Eriksson B; Ahlström H Ups J Med Sci; 2017 Mar; 122(1):43-50. PubMed ID: 27894208 [TBL] [Abstract][Full Text] [Related]
53. Advances in metabolic imaging for surgical oncology. Iagaru A; Quon A Surg Oncol Clin N Am; 2007 Apr; 16(2):273-92. PubMed ID: 17560512 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic imaging in the preoperative management of lung cancer. Imai K; Minamiya Y; Saito H; Motoyama S; Sato Y; Ito A; Yoshino K; Kudo S; Takashima S; Kawaharada Y; Kurihara N; Orino K; Ogawa J Surg Today; 2014 Jul; 44(7):1197-206. PubMed ID: 23838838 [TBL] [Abstract][Full Text] [Related]
55. [Modern imaging for liver metastases from colorectal tumors]. Gaa J; Wieder H; Schwaiger M; Rummeny EJ Chirurg; 2005 Jun; 76(6):525-6, 528-34. PubMed ID: 15875145 [TBL] [Abstract][Full Text] [Related]
56. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
57. Pilot Study of [ Eulitt PJ; Altun E; Sheikh A; Wong TZ; Woods ME; Rose TL; Wallen EM; Pruthi RS; Smith AB; Nielsen ME; Whang YE; Kim WY; Godley PA; Basch EM; David GU; Ramirez J; Deal AM; Rathmell WK; Chen RC; Bjurlin MA; Lin W; Lee JK; Milowsky MI Clin Genitourin Cancer; 2020 Oct; 18(5):378-386.e1. PubMed ID: 32147364 [TBL] [Abstract][Full Text] [Related]
58. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations. Huellner MW; Appenzeller P; Kuhn FP; Husmann L; Pietsch CM; Burger IA; Porto M; Delso G; von Schulthess GK; Veit-Haibach P Radiology; 2014 Dec; 273(3):859-69. PubMed ID: 25102372 [TBL] [Abstract][Full Text] [Related]